Effective treatment to relieve indwelling ureteral stent symptoms
Not Applicable
Completed
- Conditions
- Symptoms of indwelling ureteral stent.Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system - Unspecified complication of genitourinary prosthetic device, implant and graftT83.5 , T8
- Registration Number
- IRCT138812173509N1
- Lead Sponsor
- Vice-chancellor for research, Kermanshah University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 156
Inclusion Criteria
Ureteral stenting for treatment of ureteral obstruction due to upper tract urinary stone (kidney or ureter)
Exclusion criteria: history of urinary system surgery, BPH (IPSS>7), long standing lower urinary tract symptoms, Indwelling ureteral stent at presentation, treatment with NSAIDs or Alpha-blockers, advanced cardiac or hepatic disease, Pregnancy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Tolterodine and Tamsulosin effects on ureteral stent symptoms?
How does Tamsulosin compare to standard-of-care treatments for ureteral stent discomfort in clinical trials?
Are there specific biomarkers that predict response to anticholinergic or alpha-blocker therapies in urinary stent complications?
What are the potential adverse events associated with Tolterodine and Tamsulosin in managing stent-related inflammation?
What combination therapies or alternative drugs show promise for treating T83.5 complications in genitourinary implants?